Literature DB >> 7214799

Nalidixic acid kinetics after single and repeated oral doses.

N Ferry, G Cuisinaud, N Pozet, P Y Zech, J Sassard.   

Abstract

The kinetics of nalidixic acid (NA) and its two metabolites, 7-hydroxynalidixic acid (HNA) and 7-carboxynalidixic acid (CNA) were studied after a single oral dose and after two doses a day for 7 days. Total unconjugated NA, HNA, and CNA concentrations in plasma and urine samples were assayed by a new high-pressure liquid chromatographic (HPLC) technique. NA was rapidly absorbed and hydroxylated to HNA. Both were rapidly excreted in urine with an apparent elimination half-life (t1/2) of 6 to 7 hr. CNA was never detected in the plasma, although it accounted for about 25% of total urinary NA and metabolites. No major sex-related differences in the kinetics and the metabolic pattern were observed. During the 7-day treatment there was no significant cumulation of NA and HNA. The study demonstrated that the concentration of the active compounds, unconjugated NA and HNA, was more than five times the minimum bacteria inhibiting concentration for 8 hr after drug and slightly above this concentration during the next 4 hr.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7214799     DOI: 10.1038/clpt.1981.97

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  7 in total

1.  The effect of infinitesimal drug dilutions on the pharmacokinetics of nalidixic acid and atenolol.

Authors:  N Ferry; N Bernard; N Pozet; E Gardes; M Bruguier; G Cuisinaud; J Sassard
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

Review 2.  Quinolones as a Potential Drug in Genitourinary Cancer Treatment-A Literature Review.

Authors:  Tomasz Kloskowski; Sylwia Frąckowiak; Jan Adamowicz; Kamil Szeliski; Marta Rasmus; Tomasz Drewa; Marta Pokrywczyńska
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

3.  Probenecid inhibits the renal clearance and renal glucuronidation of nalidixic acid. A pilot experiment.

Authors:  T B Vree; M Van den Biggelaar-Martea; E W Van Ewijk-Beneken Kolmer; Y A Hekster
Journal:  Pharm World Sci       Date:  1993-08-20

4.  Direct gradient reversed-phase HPLC analysis and preliminary pharmacokinetics of nalidixic acid, 7-hydroxymethylnalidixic acid, 7-carboxynalidixic acid, and their corresponding glucuronide conjugates in humans.

Authors:  T B Vree; M van den Biggelaar-Martea; E W van Ewijk-Beneken Kolmer; Y A Hekster
Journal:  Pharm World Sci       Date:  1993-06-18

5.  Pharmacokinetics of nalidixic acid in man: hydroxylation and glucuronidation.

Authors:  T B Vree; W J Wijnands; A M Baars; Y A Hekster
Journal:  Pharm Weekbl Sci       Date:  1988-10-14

6.  Pharmacokinetics: metabolism and renal excretion of quinolones in man.

Authors:  T B Vree; W J Wijnands; P J Guelen; A M Baars; Y A Hekster
Journal:  Pharm Weekbl Sci       Date:  1986-02-21

7.  Nalidixic acid kinetics in renal insufficiency.

Authors:  G Cuisinaud; N Ferry; N Pozet; P Y Zech; J Sassard
Journal:  Br J Clin Pharmacol       Date:  1982-10       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.